Position in ABBV
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$709,373
+$237,638 QoQ
Shares Held
2,819
+30.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#2,863
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Derivatives in ABBV
reported options exposure · as of Jun 30, 2022CallValue
$0
CallShares
0
PutValue
$1,317,176
PutShares
8,600
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Lavaca Capital LLC holds $11,294,866 across 14 Drug Manufacturers - General names. ABBV ranks #2 (6.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
65,773 | $8,451,830 | |
| 2 | ABBV |
AbbVie Inc.
This page
|
2,819 | $709,373 | |
| 3 | LLY |
ELI LILLY & Co
|
486 | $582,923 | |
| 4 | JNJ |
Johnson & Johnson
|
2,093 | $531,559 | |
| 5 | AZN |
Astrazeneca PLC
|
1,648 | $312,493 | |
| 6 | PFE |
Pfizer Inc
|
10,873 | $261,821 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
1,489 | $188,120 | |
| 8 | BIIB |
Biogen Inc.
|
447 | $96,578 |
All Filings in ABBV
Export CSV
31 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $709,373 | 2,819 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $471,735 | 2,169 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $407,854 | 1,785 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $413,298 | 1,785 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $741,551 | 3,995 | Shares | Sole | 2025-08-28 | |
| 2025-03-31 | $791,147 | 3,776 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $715,064 | 4,024 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $738,180 | 3,738 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $1,307,153 | 7,621 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $1,384,142 | 7,601 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $961,588 | 6,205 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $1,360,470 | 9,127 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $1,468,422 | 10,899 | Shares | Sole | 2023-08-28 | |
| 2023-03-31 | $3,081,578 | 19,336 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $3,331,266 | 20,613 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $2,790,762 | 20,794 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,317,176 | 8,600 | Put | Sole | 2022-08-12 | |
| 2022-06-30 | $3,985,376 | 26,021 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $1,507,623 | 9,300 | Put | Sole | 2022-05-13 | |
| 2022-03-31 | $4,178,223 | 25,774 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $7,769,658 | 57,383 | Shares | Sole | 2022-02-10 | |
| 2021-12-31 | $1,286,300 | 9,500 | Put | Sole | 2022-02-10 | |
| 2021-09-30 | $7,061,385 | 65,462 | Shares | Sole | 2021-11-12 | |
| 2021-09-30 | $1,057,126 | 9,800 | Put | Sole | 2021-11-12 | |
| 2021-06-30 | $8,543,631 | 75,849 | Shares | Sole | 2021-08-13 | |
| 2021-06-30 | $1,103,872 | 9,800 | Put | Sole | 2021-08-13 | |
| 2021-03-31 | $7,493,044 | 69,239 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $6,637,835 | 61,949 | Shares | Sole | 2021-01-13 | |
| 2020-09-30 | $5,338,522 | 60,949 | Shares | Sole | 2020-11-10 | |
| 2020-06-30 | $5,306,923 | 54,053 | Shares | Sole | 2020-08-11 | |
| 2020-03-31 | $4,049,117 | 53,145 | Shares | Sole | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||